Usana Health Sciences Inc SEC filings USNA

Usana Health Sciences Inc has 1,001 filings in SEC EDGAR's recent list, going back to Nov 13, 2017. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Jan 3, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jul 4, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on January 3.

Form Description Filed Period
ARS Annual report to shareholders Apr 7, 2026 Jan 3, 2026
10-K Annual report Mar 16, 2026 Jan 3, 2026
ARS Annual report to shareholders Apr 9, 2025 Dec 28, 2024
10-K Annual report Mar 12, 2025 Dec 28, 2024
ARS Annual report to shareholders Mar 27, 2024 Dec 30, 2023
10-K Annual report Feb 27, 2024 Dec 30, 2023
ARS Annual report to shareholders Mar 31, 2023 Dec 31, 2022
10-K Annual report Feb 28, 2023 Dec 31, 2022
10-K Annual report Mar 1, 2022 Jan 1, 2022
10-K Annual report Mar 2, 2021 Jan 2, 2021
10-K Annual report Feb 25, 2020 Dec 28, 2019
10-K Annual report Feb 26, 2019 Dec 29, 2018
10-K Annual report Feb 28, 2018 Dec 30, 2017

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
USNA (NYSE)
Fiscal year ends
January 3
Incorporated in
UT
Headquarters
Salt Lake City, UT
SEC filer status
Accelerated filer
SEC CIK
896264
Former names
USANA INC (until Apr 27, 2000)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.